2 The Netherlands is well-suited for a case study to explore balancing this tension. The country has an up-to-date health care system providing adequate basic services to the whole population while enabling the provision of

extra services of personal preference; thereby, there is a mix of continental and American health care systems. The Dutch public domain has elements of Christian moral principles as well as social–democratic and more liberal influences, necessitating dialogue and seeking consensus. This public domain operates at a relative distance from the government. Coalition governments try to respect the views of their rank and file supporters as Defactinib well as integrate various standpoints into generally accepted policy. For our research, we interviewed stakeholders, organised a so-called witness seminar with 20 stakeholders who had been active in genetic

testing or screening and/or related policy issues (van El et al. 2010b), collected archival material, studied the clippings archive of VU University and collected articles in Dutch medical journals on the subject of genetic testing and screening. We will briefly discuss three occasions EZH1/2 inhibitor during the second half of the 1980s on which genetic testing and screening for reproductive issues became subject of wider attention, and were discussed in medical journals, newspapers and/or television programmes. In addition, we will discuss new regulation during the 1990s, and GDC973 changes in policy, as well as public and professional views during the 2000s. From genetic testing to genetic screening The recent decades have witnessed increasing possibilities for genetic testing and screening. In Nabilone the Netherlands, since the 1970s, individuals and their family members could obtain genetic counselling for their own risk or diagnosis of a serious genetic disorder or that of their offspring. At this time, a foundation was laid for

what was later to become the specialty of clinical genetics (Nelis 1998). Consensus on the standards of the developing profession was formulated by a relatively small group of medical professionals and experts of the Health Council of the Netherlands (1977; 1980) and was supported by representatives of emerging patient organisations. In the intimacy of the consultation room, a secluded space was defined, where doctors and patients could discuss sensitive reproductive options in case of an elevated risk for genetic or congenital disorders. During the 1980s, it became increasingly clear that new techniques might enable mass screening of pregnant women. Maternal serum screening tests were developed to detect neural tube defects, and a few years later, Down syndrome, in a foetus.